Venture investors seed GRO Biosciences’ quest for improved protein drugs
By Brian Gormley
GRO Biosciences Inc. wants to make a giant sector in the pharmaceutical industry even larger.
The spinout from the lab of Harvard Medical School geneticist George Church aims to make protein drugs more versatile and effective by recoding the genomes of bacterial strains used to make these biological medicines.
Insulin, human growth hormone…
To view original content click: https://www.wsj.com/articles/harvard-spinout-sets-sights-on-huge-drug-market-1506598200#comments_sector
